Skip to search formSkip to main contentSkip to account menu

Iohexol 300 mg in 1 mL INTRATHECAL INJECTION [Omnipaque]

Known as: Iohexol 300 mg in 1 mL INTRAVASCULAR INJECTION [Omnipaque], Iohexol 300 mg in 1 mL INTRAVENOUS INJECTION [OMNIPAQUE], Iohexol 300 mg in 1 mL ORAL INJECTION [Omnipaque] 
National Institutes of Health

Related topics

Related topics

5 relations
Hydrochloric AcidIohexolSodium HydroxideTromethamine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Mesure du débit de filtration glomérulaire (mDFG) avant et 6 mois après chirurgie bariatrique – étude pilote monocentrique
2015
2015
Interval between injection of contrast material and positive contrast cheliography affects accurate diagnosis of diaphragmatic hernia
The aim of this study was to evaluate the clinical, surgical and diagnostic imaging findings in 11 cats and 3 dogs with suspected… 
2011
2011
A Dual Radiologic Contrast Agent Protocol for 18F-FDG and 18F-FLT PET/CT Imaging of Mice Bearing Abdominal Tumors
PurposeThe aim of the study was to improve abdominal tumor detection by use of a dual radiologic contrast protocol… 
2011
2011
Gelling process differences in reverse emulsion, in situ gelling polymeric materials for intracranial aneurysm embolization, formulated with injectable contrast agents.
The use of liquid-to-solid curing materials for brain aneurysm embolization has become increasingly attractive, as liquid… 
2005
2005
Is nonionic isotonic iohexol the contrast agent of choice for quantitative myocardial videodensitometry?
SummaryAll currently used contrast media in coronary angiography induce a considerable hyperemic response interfering with the… 
1999
1999
Mechanisms of125I-omnipaque interactions with rat mononuclear phagocytes
In the absence of plasma proteins,125I-omnipaque interacts with rat isolated peritoneal macrophages due to binding to the cell… 
1997
1997
Iopentol (Imagopaque® 300) compared with iohexol (Omnipaque® 300) and diatrizoate (Urografin® 292) in pediatric urography A clinical trial assessing adverse events and diagnostic information
Summary. A double-blind, parallel-group trial was performed in 96 children in order to evaluate and compare the safety and… 
1997
1997
Iopentol (Imagopaque® 300 and 350) compared with iohexol (Omnipaque® 300 and 350) in cerebral and aortic arch angiography A clinical trial assessing adverse events and diagnostic information
Summary. The safety of the non-ionic contrast medium iopentol (Imagopaque®, Nycomed Imaging AS, Oslo, Norway) when used in… 
1994
1994
Diagnostic efficacy and safety of two low-osmolar contrast media in cerebral angiography
A comparative randomised open study was carried out in 120 patients uncle undergoing cerebral angiography, to compare two low… 
1987
1987
Clinical use of Omnipaque myelography. Report of 60 cases
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)